Hart Carl L, Ward Amie S, Haney Margaret, Comer Sandra D, Foltin Richard W, Fischman Marian W
Division on Substance Abuse, New York State Psychiatric Institute, New York, NY 10032, USA.
Psychopharmacology (Berl). 2002 Dec;164(4):407-15. doi: 10.1007/s00213-002-1231-y. Epub 2002 Sep 14.
Although smoked marijuana contains at least 60 cannabinoids, delta(9)-tetrahydrocannabinol (delta(9)-THC) is presumed to be the cannabinoid primarily responsible for many marijuana-related effects, including increased food intake and subjective effects. Yet, there has been no systematic comparison of repeated doses of oral delta(9)-THC with repeated doses of smoked marijuana in the same individuals.
To compare the effects of oral delta(9)-THC and smoked marijuana in humans under controlled laboratory conditions.
Eleven healthy research volunteers, who reported smoking an average of six marijuana cigarettes per day, completed an 18-day residential study. Marijuana cigarettes (3.1% delta(9)-THC, q.i.d.) were smoked or delta(9)-THC (20 mg, q.i.d.) was taken orally using a staggered, double-blind, double-dummy procedure for three consecutive days. Four days of placebo administration separated each active drug condition. Psychomotor task performance, subjective effects, and food intake were measured throughout the day.
Relative to placebo baseline, oral delta(9)-THC and smoked marijuana produced similar subjective-effect ratings (e.g., "high" and "mellow"), although some effects of smoked marijuana were more pronounced and less prone to the development of tolerance. Additionally, participants reported "negative" subjective effects (e.g., "irritable" and "miserable") during the days after smoking marijuana but not after oral delta(9)-THC. Both drugs increased food intake for 3 days of drug administration, but had little effect on psychomotor performance.
These results indicate that the behavioral profile of effects of smoked marijuana (3.1% delta(9)-THC) is similar to the effects of oral delta(9)-THC (20 mg), with some subtle differences.
尽管吸食的大麻含有至少60种大麻素,但δ-9-四氢大麻酚(δ-9-THC)被认为是对许多与大麻相关的效应(包括食欲增加和主观效应)起主要作用的大麻素。然而,对于同一受试者,尚未对重复剂量的口服δ-9-THC与重复剂量的吸食大麻进行系统比较。
在受控的实验室条件下比较口服δ-9-THC和吸食大麻对人体的影响。
11名健康的研究志愿者,他们报告平均每天吸食6支大麻烟,完成了一项为期18天的住院研究。采用交叉、双盲、双模拟程序,连续三天吸食大麻烟(含3.1%δ-9-THC,每日4次)或口服δ-9-THC(20毫克,每日4次)。每种活性药物给药条件之间间隔4天的安慰剂给药期。全天测量精神运动任务表现、主观效应和食物摄入量。
相对于安慰剂基线,口服δ-9-THC和吸食大麻产生了相似的主观效应评分(如“兴奋”和“放松”),尽管吸食大麻的一些效应更明显,且不太容易产生耐受性。此外,参与者在吸食大麻后的几天内报告有“负面”主观效应(如“易怒”和“难受”),但口服δ-9-THC后没有。两种药物在给药的3天内均增加了食物摄入量,但对精神运动表现影响不大。
这些结果表明,吸食大麻(含3.1%δ-9-THC)的行为效应特征与口服δ-9-THC(20毫克)相似,但存在一些细微差异。